Background Further work is required to understand the intrapulmonary pharmacokinetics of
first-line anti-tuberculosis drugs. This study aimed to describe the plasma and …

Background The contribution of immune activation to arterial stiffness and its reversibility in
human immunodeficiency virus (HIV)–infected adults in sub-Saharan Africa is unknown. …

Background Intrapulmonary pharmacokinetics may better explain response to tuberculosis (TB)
treatment than plasma pharmacokinetics. We explored these relationships by modeling …

Background Inflammation drives vascular dysfunction in HIV, but in low-income settings
causes of inflammation are multiple, and include infectious and environmental factors. We …

Background: We aim to investigate whether circulating microparticle (CMPs) subsets were
raised amongst people presenting with a new diagnosis of HIV and advanced immune …

Background Non-communicable diseases (NCDs) are increased amongst people living
with HIV (PLWH) and are driven by persistent immune activation. The role of socioeconomic …

HIV is associated with increased cardiovascular disease (CVD) risk. Despite the high prevalence
of HIV in low income sub-Saharan Africa, there are few data on the assessment of CVD …

… I am very grateful to Mishek Chammudzi, Irene Sheha and Ralph Kamngona for their
enthusiasm, support and dedication to achieving the study goals. Thanks also go to our part time …

First-line anti-tuberculosis drugs achieve higher concentrations in the lung than in plasma in
patients on treatment. Despite standard weight-based dosing, rifampicin concentrations are …

A novel magnetic nano-resin was fabricated by supporting nickel hexacyanoferrate on Fe 3
O 4 nanoparticles and immobilizing them within PAN matrix. The prepared composite was …